Beijing VbioSci Co., Ltd. is a Zhongguancun high-tech enterprise and Beijing's "specialized, refined and innovative" enterprise that mainly engages in the research, development, production and promotion of high-end veterinary biological products. The core members come from the world's top biopharmaceutical and animal health companies and have 20 years of successful development experience in immunology and animal vaccines. 10% of the company's members have a doctorate and 30% have a master's degree. The company has internationally leading subunit and genetic engineering veterinary vaccine development technology. The pipeline under development covers three major sectors: poultry, livestock, and pets, focusing on innovative varieties and major varieties. The core raw materials required for production, such as serum-free culture medium, purified fillers, and a variety of new adjuvants, are self-developed and produced by its subsidiary YSK BIOSCIENCES CO., LTD.. In 2022, the company was successfully selected into the "2022 Investment Community Healthcare Venture 50" list with its outstanding R&D strength, excellent market performance and huge development potential.
Chairman/Founder Ma Ningning
Ohio State University, USA, Biochemical Engineering , PhD
20 years of experience in vaccine research and development and antibody drug process development, internationally renowned biopharmaceutical engineering expert
Professor, Shenyang Pharmaceutical University
Servedas the senior R&D director of Pfizer in the United States, the youngestrecipient of the Pfizer Achievement Award
Servedas Deputy General Manager of SinoCellTech in China
Chief Scientist Huang Jinan
University of Melbourne, Australia, Viral Biology, PhD
20 years of experience in animal-related virus vaccine development, led 10+ vaccine projects for different species, and published a total of 28 papers in international publications
Winner of the Commonwealth Scientific and Industrial Research Institute President's Award and Pfizer's Second Quarter Corporate Innovation Award
Served as Chief scientist of the Australian R&D Department of Pfizer Animal Health
Served as Director of Zoetis Asia Pacific R&D Center